Financings In Brief
This article was originally published in The Gray Sheet
Globus Medical goes public. Exact Sciences nets $57.8 million from stock sale for cancer test. Cleveland Heart gets $30 million for artificial heart development. More financings.
You may also be interested in...
Orthofix realigns business units. Globus Medial has to pay DePuy $16 million for patent infringement. More news.
Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.